Cambridge Investment Research Advisors, Inc. Exact Sciences Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.6 Billion
Q1 2025

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 24,829 shares of EXAS stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,829

Previous 41,733 40.51%

Holding current value

$1.19 Million

Previous $2.35 Million 54.16%

% of portfolio

0.0%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 22, 2025	SELL	$43.04 - $58.51 $727,548 - $989,053	-16,904 Reduced 40.51%	24,829 $1.08 Million
Q4 2024 Feb 14, 2025	SELL	$49.33 - $71.97 $44,150 - $64,413	-895 Reduced 2.1%	41,733 $2.35 Million
Q3 2024 Oct 28, 2024	SELL	$42.43 - $70.83 $14,892 - $24,861	-351 Reduced 0.82%	42,628 $2.9 Million
Q2 2024 Jul 26, 2024	BUY	$41.33 - $74.26 $586,390 - $1.05 Million	14,188 Added 49.28%	42,979 $1.82 Million
Q1 2024 Apr 24, 2024	SELL	$56.27 - $73.77 $6,527 - $8,557	-116 Reduced 0.4%	28,791 $1.99 Million
Q4 2023 Feb 09, 2024	SELL	$59.06 - $75.72 $99,870 - $128,042	-1,691 Reduced 5.53%	28,907 $2.14 Million
Q3 2023 Oct 24, 2023	SELL	$65.94 - $99.04 $186,412 - $279,986	-2,827 Reduced 8.46%	30,598 $2.09 Million
Q2 2023 Jul 13, 2023	SELL	$62.68 - $95.05 $54,594 - $82,788	-871 Reduced 2.54%	33,425 $3.14 Million
Q1 2023 May 11, 2023	SELL	$47.19 - $70.77 $101,788 - $152,650	-2,157 Reduced 5.92%	34,296 $2.33 Million
Q4 2022 Feb 08, 2023	BUY	$30.35 - $53.15 $540,412 - $946,388	17,806 Added 95.49%	36,453 $1.81 Million
Q3 2022 Oct 17, 2022	SELL	$31.97 - $49.37 $15,761 - $24,339	-493 Reduced 2.58%	18,647 $605,000
Q2 2022 Jul 13, 2022	SELL	$35.61 - $76.23 $592,479 - $1.27 Million	-16,638 Reduced 46.5%	19,140 $753,000
Q1 2022 May 12, 2022	SELL	$57.56 - $82.54 $331,085 - $474,770	-5,752 Reduced 13.85%	35,778 $2.5 Million
Q4 2021 Feb 03, 2022	BUY	$72.5 - $100.68 $171,317 - $237,906	2,363 Added 6.03%	41,530 $3.23 Million
Q3 2021 Nov 02, 2021	BUY	$90.24 - $124.05 $105,310 - $144,766	1,167 Added 3.07%	39,167 $3.74 Million
Q2 2021 Aug 10, 2021	BUY	$93.66 - $139.27 $3.56 Million - $5.29 Million	38,000 New	38,000 $4.72 Million
Q1 2021 May 07, 2021	SELL	$116.57 - $155.01 $4.25 Million - $5.66 Million	-36,483 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$99.61 - $142.12 $479,323 - $683,881	4,812 Added 15.19%	36,483 $4.83 Million
Q3 2020 Oct 29, 2020	SELL	$72.92 - $102.01 $3,646 - $5,100	-50 Reduced 0.16%	31,671 $3.23 Million
Q2 2020 Jul 27, 2020	SELL	$55.75 - $92.75 $119,360 - $198,577	-2,141 Reduced 6.32%	31,721 $2.76 Million
Q1 2020 May 08, 2020	BUY	$37.9 - $104.44 $293,383 - $808,470	7,741 Added 29.64%	33,862 $1.96 Million
Q4 2019 Feb 04, 2020	SELL	$77.66 - $99.74 $437,769 - $562,234	-5,637 Reduced 17.75%	26,121 $2.42 Million
Q3 2019 Nov 06, 2019	BUY	$90.37 - $122.49 $41,208 - $55,855	456 Added 1.46%	31,758 $2.87 Million
Q2 2019 Aug 15, 2019	BUY	$89.51 - $118.04 $188,418 - $248,474	2,105 Added 7.21%	31,302 $0
Q1 2019 May 08, 2019	BUY	$61.98 - $96.5 $667,648 - $1.04 Million	10,772 Added 58.46%	29,197 $0
Q4 2018 Feb 05, 2019	SELL	$56.04 - $82.66 $525,262 - $774,772	-9,373 Reduced 33.72%	18,425 $1.16 Million
Q3 2018 Nov 02, 2018	BUY	$48.29 - $80.6 $161,240 - $269,123	3,339 Added 13.65%	27,798 $0
Q2 2018 Aug 10, 2018	BUY	$37.84 - $69.96 $361,372 - $668,117	9,550 Added 64.06%	24,459 $0
Q1 2018 May 09, 2018	SELL	$39.82 - $57.53 $18,436 - $26,636	-463 Reduced 3.01%	14,909 $0
Q4 2017 Feb 22, 2018	SELL	$46.49 - $60.51 $103,254 - $134,392	-2,221 Reduced 12.62%	15,372 $0
Q3 2017 Nov 07, 2017	BUY	$37.05 - $47.12 $225,560 - $286,866	6,088 Added 52.92%	17,593 $829,000
Q2 2017 Aug 08, 2017	BUY	N/A	11,505	11,505 $407,000

Others Institutions Holding EXAS

# of Institutions

636

Shares Held

157M

Call Options Held

1.64M

Put Options Held

1.5M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Exact Sciences Corp Transaction History